TAKKT (TTK) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Q1 2025 performance showed top-line stabilization despite a volatile macro environment and US tariff uncertainty, with organic sales down 7.6% year-over-year.
Gross profit margin improved sequentially to 39.8%, but adjusted EBITDA margin dropped to 4.9% from 7.4% last year due to challenging market conditions.
Free cash flow was negative at EUR 5 million, impacted by temporary inventory investments, with expectations to turn positive in coming quarters.
Strategic focus on core businesses, especially Industrial & Packaging, with ongoing cost management, efficiency initiatives, and tariff mitigation measures.
Extensive measures implemented to counter higher US tariffs, including supplier renegotiations, price adjustments, and alternative sourcing.
Financial highlights
Q1 sales were EUR 251.5 million, down 6.5% year-over-year; organic growth at -7.6%.
Adjusted EBITDA margin at 4.9% (vs. 7.4% prior year); reported EBITDA margin at 4.4% (6.2% prior year).
Free cash flow negative at EUR 5 million, compared to EUR 21.3 million in Q1 2024, due to inventory build-up.
Net financial liabilities at EUR 117.8 million; equity ratio at 59.1%.
Cash flow from operating activities at EUR 0.7 million, down from EUR 27.8 million in Q1 2024.
Outlook and guidance
Full-year 2025 guidance confirmed: organic sales growth between -4% and +6%, adjusted EBITDA margin between 6% and 8%.
Free cash flow expected to turn positive from Q2 2025 as inventories are reduced; cash conversion targeted at 60%-80% of EBITDA.
Gradual recovery in top-line expected in H2, driven by commercial and cost initiatives.
Guidance assumes resolution or compromise on tariffs, especially between China and the U.S.
Cost management measures to be intensified, with possible higher one-off expenses.
Latest events from TAKKT
- 2025 sales and earnings fell, but structural improvements support margin recovery in 2026.TTK
Q4 202526 Mar 2026 - Sales and EBITDA fell in 2025, but free cash flow stayed positive and dividend was suspended.TTK
Q4 2025 TU24 Feb 2026 - Sales and profit fell sharply in H1 2024, but cash flow and margins showed resilience.TTK
Q2 20243 Feb 2026 - Sales and profit remain under pressure, but operational fixes are driving gradual improvement.TTK
Q3 202418 Jan 2026 - Sales and profit fell, but strong cash flow and a €0.60 dividend proposal provide stability.TTK
Q4 202423 Dec 2025 - Strategy focuses on core growth, digitalization, and >10% EBITDA margin by 2028.TTK
CMD 20252 Dec 2025 - Sales, earnings, and cash flow declined amid tariffs and weak demand; cost-saving actions intensified.TTK
Q2 202516 Nov 2025 - Sales and margins fell, but Q3 cash flow turned positive amid ongoing restructuring and market headwinds.TTK
Q3 202529 Oct 2025